KL-50 in post TMZ MMR-deficient GBM
Update: 2025-02-22
Description
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
